NOVAREX Co.Ltd (194700) - Total Liabilities
Based on the latest financial reports, NOVAREX Co.Ltd (194700) has total liabilities worth ₩112.55 Billion KRW (≈ $76.27 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
NOVAREX Co.Ltd - Total Liabilities Trend (2015–2025)
This chart illustrates how NOVAREX Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. See 194700 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
NOVAREX Co.Ltd Competitors by Total Liabilities
The table below lists competitors of NOVAREX Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
BBMG Corporation
F:9BM
|
Germany | €174.70 Billion |
|
Jinzhou Port Co Ltd A
SHG:600190
|
China | CN¥9.91 Billion |
|
Fountaine Pajo
PA:ALFPC
|
France | €185.90 Million |
|
Vivozon Healthcare Inc
KQ:082800
|
Korea | ₩73.01 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.00 Billion |
|
Stellar V Capital Corp. Class A Ordinary Shares
NASDAQ:SVCC
|
USA | $5.37 Million |
|
Athens Medical C.S.A.
AT:IATR
|
Greece | €416.15 Million |
|
Dividend 15 Split Corp II
TO:DF
|
Canada | CA$253.81 Million |
Liability Composition Analysis (2015–2025)
This chart breaks down NOVAREX Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see NOVAREX Co.Ltd market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NOVAREX Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NOVAREX Co.Ltd (2015–2025)
The table below shows the annual total liabilities of NOVAREX Co.Ltd from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩104.91 Billion ≈ $71.10 Million |
+51.29% |
| 2024-12-31 | ₩69.35 Billion ≈ $47.00 Million |
+7.82% |
| 2023-12-31 | ₩64.32 Billion ≈ $43.59 Million |
-27.91% |
| 2022-12-31 | ₩89.21 Billion ≈ $60.46 Million |
-22.40% |
| 2021-12-31 | ₩114.96 Billion ≈ $77.91 Million |
+15.09% |
| 2020-12-31 | ₩99.89 Billion ≈ $67.70 Million |
+59.62% |
| 2019-12-31 | ₩62.58 Billion ≈ $42.41 Million |
+128.43% |
| 2018-12-31 | ₩27.40 Billion ≈ $18.57 Million |
+37.52% |
| 2017-12-31 | ₩19.92 Billion ≈ $13.50 Million |
+27.79% |
| 2016-12-31 | ₩15.59 Billion ≈ $10.56 Million |
-21.77% |
| 2015-12-31 | ₩19.93 Billion ≈ $13.51 Million |
-- |
About NOVAREX Co.Ltd
NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science C… Read more